ConspectusThe eukaryotic heme oxygenases (HOs) (E.C. 1.14.99.3) convert heme
to biliverdin, iron, and carbon monoxide (CO) in three successive
oxygenation steps. Pathogenic bacteria require iron for survival and
infection. Extracellular heme uptake from the host plays a critical
role in iron acquisition and virulence. In the past decade, several
HOs required for the release of iron from extracellular heme have
been identified in pathogenic bacteria, including Corynebacterium
diphtheriae, Neisseriae meningitides, and Pseudomonas aeruginosa. The
bacterial enzymes were shown to be structurally and mechanistically
similar to those of the canonical eukaryotic HO enzymes. However,
the recent discovery of the structurally and mechanistically distinct
noncanonical heme oxygenases of Staphylococcus aureus and Mycobacterium tuberculosis has
expanded the reaction manifold of heme degradation. The distinct ferredoxin-like
structural fold and extreme heme ruffling are proposed to give rise
to the alternate heme degradation products in the S.
aureus and M. tuberculosis enzymes. In addition, several “heme-degrading factors”
with no structural homology to either class of HOs have recently been
reported. The identification of these “heme-degrading proteins”
has largely been determined on the basis of in vitro heme degradation
assays. Many of these proteins were reported to produce biliverdin,
although no extensive characterization of the products was performed.
Prior to the characterization of the canonical HO enzymes, the nonenzymatic
degradation of heme and heme proteins in the presence of a reductant
such as ascorbate or hydrazine, a reaction termed “coupled
oxidation”, served as a model for biological heme degradation.
However, it was recognized that there were important mechanistic differences
between the so-called coupled oxidation of heme proteins and enzymatic
heme oxygenation. In the coupled oxidation reaction, the final product,
verdoheme, can readily be converted to biliverdin under hydrolytic
conditions. The differences between heme oxygenation by the canonical
and noncanonical HOs and coupled oxidation will be discussed in the
context of the stabilization of the reactive FeIII–OOH
intermediate and regioselective heme hydroxylation. Thus, in the determination
of heme oxygenase activity in vitro, it is important to ensure that
the reaction proceeds through successive oxygenation steps. We further
suggest that when bacterial heme degradation is being characterized,
a systems biology approach combining genetics, mechanistic enzymology,
and metabolite profiling should be undertaken.